Biossil

Toronto, Canada

Biossil is an applied AI drug discovery platform to create specialized treatments for distinct patients.

$70.0M raised

Apr 2026

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Biossil raised?

Biossil has raised $70.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.

Who are Biossil's investors?

Biossil's investors include OpenAI, Founders Fund, Quiet Capital, 137 Ventures, Panache Ventures.

Where is Biossil headquartered?

Biossil is headquartered in Toronto, Canada.

What does Biossil do?

Biossil is an applied AI drug discovery platform to create specialized treatments for distinct patients.

What stage is Biossil at?

Biossil is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 23, 2026.

MLA

"Biossil — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/biossil. Accessed July 2, 2026.

APA

VCBacked. (2026). Biossil — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/biossil

Wikipedia (cite web)

{{cite web |title=Biossil — Funding & Investors |url=https://www.vcbacked.co/company/biossil |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 23, 2026.